Get startedLog in
    Picture of PAION AG logo

    PA8 — PAION AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Paion Submits Extension Application Of Marketing Authorization For Remimazolam

    Picture of PAION AG logoPAION AG
    03/01/2022 06:56
    Jan 3 (Reuters) - PAION AG  PA8G.DE :
    * SAID ON FRIDAY: SUBMITS EXTENSION APPLICATION OF MARKETING
AUTHORIZATION FOR REMIMAZOLAM IN THE INDICATION GENERAL
ANESTHESIA TO THE EUROPEAN MEDICINES AGENCY
    * DECISION BY EMA IS EXPECTED AT END OF 2022 OR BEGINNING OF
2023

Source text for Eikon:  ID:nEQ6M5FDDa 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on PAION AG

    See all news